Table 4.
Percent availability and median MPRs of different antimicrobials by type of health care facility
| ADDOs n = 94 | Public health care facilities n = 72 | Private pharmacies n = 13 | ||||
|---|---|---|---|---|---|---|
| % Availability [95 % CI] | Median MPR (25th, 75th percentiles)a, b | % Availability [95 % CI] | Median MPR (25th, 75th percentiles)a, b | % Availability [95 % CI] | Median MPR (25th, 75th percentiles)a | |
| All antimicrobials | 5.3 [2.2, 12.3] | 0.0 [., .] | 61.5 [31.0, 85.1] | |||
| All suspension formulations | 60.6 [48.7, 71.4] | 22.2 [13.4, 34.5] | 76.9 [46.5, 92.8] | |||
| Amoxicillin trihydrate 250 mg caps | 81.9 [72.6, 88.6] | 2.25 (1.69, 2.70) | 86.1 [74.9, 92.8] | 1.69 (1.35, 2.70) | 100.0 [., .] | 1.69 (1.69, 2.36) |
| Amoxicillin trihydrate 125 mg/5 mL suspension | 86.2 [77.0, 92.1] | 1.96 (1.84, 2.45) | 62.0 [49.2, 73.3] | 1.84 (1.10, 2.45) | 100.0 [., .] | 1.84 (1.22, 2.45) |
| Co-trimoxazole 480 mg tablets | 87.2 [78.9, 92.6] | 2.65 (2.12, 3.19) | 84.7 [73.9, 91.6] | 1.86 (1.33, 2.65) | 92.3 [59.7, 99.0] | 2.65 (2.39, 2.65) |
| Co-trimoxazole 240 mg/5 mL suspension | 89.4 [81.3, 94.2] | 1.80 (1.80, 2.40) | 60.6 [48.0, 71.9] | 1.80 (1.13, 2.22) | 92.3 [59.7, 99.0] | 1.80 (1.20, 2.40) |
| Erythromycin 250 mg tablets | 75.5 [64.8, 83.8] | 1.59 (1.32, 1.59) | 83.1 [69.7, 91.3] | 1.30 (0.63, 1.59) | 100.0 [., .] | 1.59 (1.59, 1.59) |
| Erythromycin 125 mg/5 mL suspension | 74.5 [63.2, 83.2] | 1.33 (1.33, 1.67) | 54.2 [41.4, 66.4] | 1.33 (1.21, 1.73) | 92.3 [59.7, 99.0] | 1.33 (1.33, 1.50) |
| Metronidazole 200 mg tablets | 90.4 [83.0, 94.8] | 3.28 (2.95, 4.92) | 93.1 [84.0, 97.2] | 2.46 (1.64, 3.93) | 92.3 [59.7, 99.0] | 3.11 (1.97, 4.92) |
| Metronidazole 200 mg/5 mL suspension | 80.9 [71.0, 87.9] | 3.24 (2.43, 3.24) | 29.2 [19.2, 41.7] | 2.43 (1.70, 3.24) | 92.3 [59.7, 99.0] | 2.43 (2.19, 3.24) |
| Ampicillin 250 mg caps | 29.8 [21.3, 40.0] | 2.14 (1.60, 2.25) | 7.0 [2.9, 16.0] | 2.57 (1.60, 3.08) | 69.2 [42.7, 87.2] | 1.60 (1.28, 1.60) |
| Ciprofloxacin 500 mg tablets | 36.2 [26.9, 46.6] | 2.38 (1.59, 3.17) | 76.4 [63.2, 85.9] | 2.38 (1.59, 3.02) | 100.0 [., .] | 1.59 (1.59, 2.38) |
| Ampicillin/ cloxacillin 500 mg caps | 31.9 [22.9, 42.5] | Not available | 23.6 [14.8, 35.5] | Not available | 100.0 [., .] | Not available |
| Doxycycline 100 mg caps/tablets | 60.6 [50.6, 69.8] | 4.17 (3.33, 4.17) | 86.1 [75.1, 92.7] | 4.17 (2.08, 4.17) | 100.0 [., .] | 4.17 (2.08, 4.17) |
| Tetracycline 250 mg caps | 28.3 [19.9, 38.4] | 2.26 (2.26, 2.63) | 8.3 [3.7, 17.8] | 2.26 (0.90, 2.26) | 92.3 [59.7, 99.0] | 2.26 (2.03, 2.26) |
| Procaine penicillin fortified 4MU, powder for injection | 52.1 [41.1, 63.0] | 2.23 (1.78, 2.23) | 62.5 [51.2, 72.6] | 2.01 (0.72, 2.79) | 76.9 [49.9, 91.8] | 1.78 (1.56, 2.23) |
| Benzyl penicillin 5MU, powder for injection | 44.7 [33.3, 56.6] | 2.44 (2.19, 2.44) | 88.9 [78.3, 94.7] | 2.44 (1.22, 3.05) | 84.6 [57.2, 95.8] | 1.95 (1.71, 2.44) |
This table shows the percent availability and median prices in relation to international reference prices of different antimicrobials by type of health care facility
a Median price ratio (MPR) = median unit price in outlets/International Drug Price Indicator Guide reference procurement price
b Comparison of the 14 available antimicrobials median MPRs between ADDOs and public health care facilities: p = 0.0425 (paired t-test)